Back to top

Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing

Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AMNEAL PHARMACEUTICALS, INC. (AMRX)

Eli Lilly and Company (LLY)

Regeneron Pharmaceuticals, Inc. (REGN)